Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$0.31 - $0.55 $17,158 - $30,441
-55,349 Reduced 62.26%
33,551 $17,000
Q1 2023

May 12, 2023

BUY
$0.32 - $1.88 $23,328 - $137,052
72,900 Added 455.63%
88,900 $30,000
Q4 2022

Feb 13, 2023

BUY
$0.35 - $20.75 $1,085 - $64,325
3,100 Added 24.03%
16,000 $6,000
Q2 2022

Aug 12, 2022

BUY
$1.12 - $2.18 $2,240 - $4,360
2,000 Added 18.35%
12,900 $17,000
Q1 2022

May 13, 2022

BUY
$1.63 - $3.63 $17,767 - $39,567
10,900 New
10,900 $29,000
Q3 2021

Nov 12, 2021

SELL
$2.71 - $5.9 $52,032 - $113,280
-19,200 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$4.83 - $9.67 $92,736 - $185,664
19,200 New
19,200 $95,000

About Vivos Therapeutics, Inc.


  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $60.3M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.